<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M833</article-id>
      <article-id pub-id-type="publisher-id">molbank-2014-M833</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>N</italic><sup>2</sup>-<italic>tert</italic>-Butoxycarbonyl-<italic>N</italic><sup>5</sup>-[<italic>N</italic>-(9-fluorenylmethyloxycarbonyl)-2-aminoethyl]-(<italic>S</italic>)-2,5-diaminopentanoic Acid</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Maity</surname>
            <given-names>Jyotirmoy</given-names>
          </name>
          <xref rid="c1-molbank-2014-M833" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stromberg</surname>
            <given-names>Roger</given-names>
          </name>
          <xref rid="c1-molbank-2014-M833" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2014-M833">Department of Biosciences and Nutrition, Karolinska Institute (KI), Novum, Huddinge SE-141 83, Sweden</aff>
      <author-notes>
        <corresp id="c1-molbank-2014-M833"><label>*</label> Authors to whom correspondence should be addressed; E-Mails: <email>Roger.Stromberg@ki.se</email> (R.S.); <email>Jyotirmoy.Maity@ki.se</email> (J.M.); Tel.: +46-8-5248-1024 (R.S.); +46-8-5248-1219 (J.M.).</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>08</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>09</month>
        <year>2014</year>
      </pub-date>
      <volume>2014</volume>
      <issue>3</issue>
      <elocation-id>M833</elocation-id>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>04</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>08</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2014 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p><italic>N</italic><sup>2</sup>-<italic>tert</italic>-Butoxycarbonyl-<italic>N</italic><sup>5</sup>-[<italic>N</italic>-(9-fluorenylmethyloxycarbonyl)-2-aminoethyl]-(<italic>S</italic>)-2,5-diaminopentanoic acid (<bold>5</bold>) has been synthesized by the reaction of <italic>N</italic><sup>2</sup>-<italic>tert</italic>-butoxycarbonyl-L-2,5-diaminopentanoic acid (Boc-L-ornithine, <bold>3</bold>) and <italic>N</italic>-Fmoc-2-aminoacetaldehyde (<italic>N</italic>-Fmoc-glycinal, <bold>4</bold>) in the presence of sodium cyanoborohydride in methanol containing 1% acetic acid at room temperature.</p>
      </abstract>
      <kwd-group>
        <kwd>reductive amination</kwd>
        <kwd><italic>N</italic><sup>2</sup>-<italic>tert</italic>-butoxycarbonyl-<italic>N</italic><sup>5</sup>-[<italic>N</italic>-(9-fluorenylmethyloxycarbonyl)-2-aminoethyl]-(<italic>S</italic>)-2,5-diaminopentanoic acid</kwd>
        <kwd><sup>&#x3B4;</sup>N-(2-aminoethyl)-L-ornithine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Ornithine (<bold>1</bold>, <xref ref-type="fig" rid="molbank-2014-M833-f001">Figure 1</xref>) is a non proteinogenic amino acid, which plays an important role in ammonia metabolism via the urea cycle. Its intake has been recommended as a nutritional supplement for its antifatigue effect [<xref ref-type="bibr" rid="B1-molbank-2014-M833">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2014-M833">2</xref>]. <italic>N</italic><sup>5</sup>-Ornithine derivatives showed their potential as orally active non-peptide fibrinogen receptor antagonists [<xref ref-type="bibr" rid="B3-molbank-2014-M833">3</xref>] and selective prostaglandin EP<sub>4</sub> receptor antagonists [<xref ref-type="bibr" rid="B4-molbank-2014-M833">4</xref>]. L-<italic>N</italic><sup>5</sup>-(1-Iminoethyl)-ornithine dihydrochloride (<bold>2</bold>, <xref ref-type="fig" rid="molbank-2014-M833-f001">Figure 1</xref>) was used for studies of bactericidal activity of human eosinophilic granulocytes against <italic>Escherichia coli</italic> [<xref ref-type="bibr" rid="B5-molbank-2014-M833">5</xref>]. The capability of the <italic>N</italic><sup>5</sup>-ornithine derivatives as biologically active agents inspired us to synthesize its new-fangled derivatives.</p>
      <p>Reductive amination has become a versatile and practical method for the preparation of amines in organic synthesis. New catalysts for reductive amination exemplify organocatalysts, complexes of transition metals (Ru, Rh, Ir), reagents involving boron, tin and silicon [<xref ref-type="bibr" rid="B6-molbank-2014-M833">6</xref>]. This reaction has found its application for the synthesis of natural products, drug molecules and chiral ligands. In this short note, we describe a reductive amination between <italic>N</italic><sup>2</sup>-<italic>tert</italic>-butoxycarbonyl-L-2,5-diaminopropionic acid (<bold>3</bold>) and <italic>N</italic>-Fmoc-2-aminoacetaldehyde (<italic>N</italic>-Fmoc-glycinal, <bold>4</bold>) to derivatize the ornithine moiety by converting its <italic>N</italic><sup>5</sup>-primary amine into a secondary amine and extending it with an aminoethyl group; thus producing the building block for the new triamino acid <sup>&#x3B4;</sup>N-(2-aminoethyl)ornithine (<xref ref-type="scheme" rid="molbank-2014-M833-sch001">Scheme 1</xref>). As judged by thin layer chromatography (TLC), the Fmoc seems to survive the conditions, but it is possible that some of the aldehyde was consumed by direct reaction with the borohydride, resulting in a moderate yield. Although a change of reagent perhaps could have improved the outcome, we found the isolated yield after chromatography quite acceptable, considering that only 0.9 equivalents of aldehyde was used (for simplicity of purification).</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>N<sup>2</sup>-tert-Butoxycarbonyl-N<sup>5</sup>-[N-(9-fluorenylmethyloxycarbonyl)-2-aminoethyl]-(S)-2,5-diaminopentanoic acid <italic>(<bold>5</bold>)</italic></title>
        <p><italic>N</italic><sup>2</sup>-<italic>tert</italic>-Butoxycarbonyl-L-2,5-diaminopropionic acid (<bold>3</bold>, Boc-L-ornithine, 0.116 g, 0.5 mmol) was dissolved in a solvent mixture (acetic acid/methanol, 1:99, v/v, 10 mL) at rt under stirring. <italic>N</italic>-Fmoc-2-aminoacetaldehyde (<bold>4</bold>, <italic>N</italic>-Fmoc-glycinal, 0.129 g, 0.46 mmol) [<xref ref-type="bibr" rid="B7-molbank-2014-M833">7</xref>] was added into the reaction mixture slowly followed by addition of NaBH<sub>3</sub>CN (0.072 g, 1.14 mmol) in a single lot. The reaction mixture was stirred at rt and the progress of the reaction was monitored by thin layer chromatography. After 18 h, the reaction mixture was evaporated to dryness under reduced pressure and was dissolved in ethyl acetate (15 mL). Organic layer was washed with water (10 mL) and brine (10 mL &#xD7; 2), dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness under reduced pressure to get crude compound. Pure compound was obtained by purification of the crude using column chromatography (2%&#x2013;4% methanol in dichloromethane containing 1% acetic acid) to afford pure compound <bold>5</bold> (0.104 g, 42%).</p>
        <p>Physical characteristics: White sticky solid.</p>
        <p>Yield: 0.104 g, 42%.</p>
        <p>R<italic><sub>f</sub></italic> = 0.17 (Methanol/dichloromethane/acetic acid = 1:8.9:0.1, v/v/v).</p>
        <p><sup>1</sup>H-NMR (400 MHz, CD<sub>3</sub>OD) (&#x3B4;/ppm): 7.70 (2H, d, <italic>J</italic> = 7.6 Hz, Ar-H), 7.55 (2H, d, <italic>J</italic> = 7.6 Hz, Ar-H), 7.29 (2H, d, <italic>J</italic> = 7.6 Hz, Ar-H), 7.21 (2H, d, <italic>J</italic> = 7.6 Hz, Ar-H), 4.32 (2H, d, <italic>J</italic> = 6.8 Hz, NCOOC<italic><underline>H</underline></italic><sub>2</sub>CH), 4.11 (1H, t, <italic>J</italic> = 6.8 Hz, NCOOCH<sub>2</sub>C<italic><underline>H</underline></italic>), 3.86 (1H, br s, 2-CH), 3.31 (2H, t, <italic>J</italic> = 5.6 Hz, NCH<sub>2</sub>C<italic><underline>H</underline></italic><sub>2</sub>NHFmoc), 2.98 (2H, t, <italic>J</italic> = 5.6 Hz, NC<italic><underline>H</underline></italic><sub>2</sub>CH<sub>2</sub>NHFmoc), 2.90 (2H, t, <italic>J</italic> = 5.6 Hz, 5-CH<sub>2</sub>), 1.74&#x2013;1.61 (4H, m, 3-CH<sub>2</sub>, 4-CH<sub>2</sub>), 1.32 (9H, s, C(CH<sub>3</sub>)<sub>3</sub>).</p>
        <p><sup>13</sup>C-NMR (100 MHz, CD<sub>3</sub>OD) (&#x3B4;/ppm), methine and methyl carbons were distinguished from methylene carbons by <sup>13</sup>C-DEPT: 179.5 (COOH), 159.2, 157.6 (2 &#xD7; NCOO), 145.2, 142.6 (C-Ar), 128.8, 128.1, 126.1, 120.9 (CH-Ar), 80.2 (<italic><underline>C</underline></italic>(CH<sub>3</sub>)<sub>3</sub>), 68.0 (NCOO<italic><underline>C</underline></italic>H<sub>2</sub>CH), 56.2 (C-2), 48.8, 48.6 (C-5, N<italic><underline>C</underline></italic>H<sub>2</sub>CH<sub>2</sub>NHFmoc), 48.4 (NCOOCH<sub>2</sub><italic><underline>C</underline></italic>H), 38.5 (NCH<sub>2</sub><italic><underline>C</underline></italic>H<sub>2</sub>NHFmoc), 31.3 (C-3), 28.8 (C(<italic><underline>C</underline></italic>H<sub>3</sub>)<sub>3</sub>), 23.5 (C-4).</p>
        <p>IR (KBr) &#x3BD;<sub>max</sub> 3433, 1700, 1570, 1415, 1355, 1250, 1160, 1050, 957, 815, 725, 692 and 620 cm<sup>&#x2212;1</sup>.</p>
        <p>Optical rotation: <mml:math id="mm1">
            <mml:mrow>
			<mml:msubsup>
			<mml:mrow>
			<mml:mo>[</mml:mo>
			<mml:mi mathvariant="sans-serif">&#x3B1;</mml:mi>
			<mml:mo>]</mml:mo>
			</mml:mrow>
              <mml:mi>D</mml:mi>
			  <mml:mn>27</mml:mn>
			</mml:msubsup>
            </mml:mrow>
          </mml:math> +8.2 (<italic>c</italic> 1.0, MeOH).</p>
        <p>HRMS (ESI-Tof) <italic>(m/z)</italic> calcd for C<sub>27</sub>H<sub>34</sub>N<sub>3</sub>O<sub>6</sub><sup>&#x2212;</sup> [M-H]<sup>&#x2212;</sup> 496.2453; found 496.2463.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2014-M833">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2014-M833-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M833-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2014-M833-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M833-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We would like to thank the Swedish Research Council for financial support.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>JM and RS planned the work, JM carried out all experimental work, JM and RS wrote the manuscript together.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2014-M833">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugino</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Shiri</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kajimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kajimoto</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>L-Ornithine supplementation attenuates physical fatigue in healthy volunteers by modulation lipid and amino acid metabolism</article-title>
          <source>Nutr. Res.</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>738</fpage>
          <lpage>743</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nutres.2008.08.008</pub-id>
          <pub-id pub-id-type="pmid">19083482</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2014-M833">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demura</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamaji</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Komatsu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Morishita</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The effect of L-ornithine hydrochloride ingestion on performance during incremental exhaustive ergometer bicycle exercise and ammonia metabolism during and after exercise</article-title>
          <source>Eur. J. Clin. Nutr.</source>
          <year>2010</year>
          <volume>64</volume>
          <fpage>1166</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="doi">10.1038/ejcn.2010.149</pub-id>
          <pub-id pub-id-type="pmid">20717126</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2014-M833">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kottirsch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zerwes</surname>
              <given-names>H.-G.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Tapparelli</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Beta-amino acid derivatives as orally active non-peptide fibrinogen receptor antagonists</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>727</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-894X(97)00095-4</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2014-M833">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hattori</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Takasugi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tenda</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tomita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nakazato</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kono</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery of diphenyloxazole and <italic>N</italic><sup>&#x3B4;</sup>-Z-ornithine derivatives as highly potent and selective human prostaglandin EP<sub>4</sub> receptor antagonists</article-title>
          <source>J. Med. Chem.</source>
          <year>2005</year>
          <volume>48</volume>
          <fpage>3103</fpage>
          <lpage>3106</lpage>
          <pub-id pub-id-type="doi">10.1021/jm050085k</pub-id>
          <pub-id pub-id-type="pmid">15857112</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2014-M833">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Persson</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bodelsson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Laurell</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Malm</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Egesten</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Bactericidal activity of human eosinophilic granucytes against <italic>Escherichia coli</italic></article-title>
          <source>Infect. Immun.</source>
          <year>2001</year>
          <volume>69</volume>
          <fpage>3591</fpage>
          <lpage>3596</lpage>
          <pub-id pub-id-type="doi">10.1128/IAI.69.6.3591-3596.2001</pub-id>
          <pub-id pub-id-type="pmid">11349018</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2014-M833">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tripathi</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Pandey</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tiwati</surname>
              <given-names>V.K.</given-names>
            </name>
          </person-group>
          <article-title>Recent development on catalytic reductive amination and applications</article-title>
          <source>Curr. Org. Chem.</source>
          <year>2008</year>
          <volume>12</volume>
          <fpage>1093</fpage>
          <lpage>1115</lpage>
          <pub-id pub-id-type="doi">10.2174/138527208785740283</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2014-M833">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumori</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Amphoteric B covalent dimers bearing a tartarate linkage</article-title>
          <source>Chem. Biodivers.</source>
          <year>2004</year>
          <volume>1</volume>
          <fpage>346</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="doi">10.1002/cbdv.200490030</pub-id>
          <pub-id pub-id-type="pmid">17191852</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figure and Scheme</title>
      <fig id="molbank-2014-M833-f001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Structures of L-ornithine (<bold>1</bold>) and L-<italic>N</italic><sup>5</sup>-(1-iminoethyl)-ornithine dihydrochloride (<bold>2</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M833-g001.tif"/>
      </fig>
      <fig id="molbank-2014-M833-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2014-M833-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of title compound <bold>5</bold> from Boc-L-ornithine.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M833-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
